So TLR4, NF-κB, NLRP3 inflammasome have been considered as promising pharmacological targets for inflammatory diseases, including ALI and pneumonia (Du et al., 2019; Wu et al., 2020; Yao et al., 2017). The gene discussed is NFKB1; the disease is acute respiratory distress syndrome.